Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-29

Clinical Trial Update: Treatment of Chronic Laryngitis With Amitriptyline [Phase 2, Phase 3]

View source ↗

Summary

A randomized trial investigating amitriptyline for chronic laryngitis was terminated with posted results, spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • amitriptyline (amitriptyline)

Snippet

Sponsor: Boston Medical Center | Conditions: Laryngeal Diseases | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2021-10-29